Qi Xia, PhD

Abbvie

Qi Xia is the Statistics TA Head, Oncology, at Abbvie, responsible for all statistical deliverables within the oncology TA, from first-in-human studies to regulatory approvals. She provides strategic, operational, and technical guidance to product and project level statisticians, and ensure the oncology TA provides scientifically sound development strategies that incorporate both current best practices and innovative approaches. Prior to joining Abbvie, she was a Senior Director at Genentech/Roche, overseeing the data sciences and statistics group supporting late-stage development of multiple molecules across different disease indications and development stages . She received her Ph.D in Statistics from Rutgers University. Qi is passionate about rigorous drug development, innovative trial design, and robust decision making. She is particularly interested in improving drug development via practical innovation and increased efficiency.